2026 Global: Anesthesia And Respiratory Device Market -Competitive Review (2032) report
Description
The 2026 Global: Anesthesia And Respiratory Device Market -Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for anesthesia and respiratory device market by geography and historical trend. The scope of the report extends to sizing of the anesthesia and respiratory device market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Medtronic PLC, GE Healthcare, Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, and B. Braun Melsungen AG lead the anesthesia and respiratory device market, alongside Smiths Medical, Teleflex Incorporated, Fisher & Paykel Healthcare, ResMed, and Masimo Corporation, dominating through innovations in ventilators, monitoring systems, and airway management. These companies drive a market valued at USD 50.45 billion in 2025, projected to reach USD 90.18 billion by 2034 at a 6.64% CAGR, fueled by rising respiratory disorders like COPD and surgical volumes. Medtronic, headquartered in Ireland, excels in advanced ventilators and anesthesia delivery, integrating AI for patient outcomes across cardiovascular and respiratory care. GE Healthcare, based in Chicago, offers cutting-edge anesthesia workstations with real-time monitoring and digital connectivity for global hospitals. Philips, from Amsterdam, provides modular monitoring and noninvasive ventilation, emphasizing AI analytics and interoperability.
Drägerwerk AG & Co. KGaA, in Lübeck, Germany, specializes in anesthesia machines, ventilators, and patient monitoring, supporting critical care worldwide since 1889. B. Braun Melsungen AG delivers infusion pumps, regional anesthesia systems, and safety needles, enhancing perioperative workflows. Smiths Medical (ICU Medical) focuses on airway devices like endotracheal tubes and infusion therapy for vital care. Teleflex Incorporated advances critical care with laryngeal masks and intubation tools, improving surgical efficiency. Fisher & Paykel Healthcare, from New Zealand, innovates in humidifiers and masks for acute respiratory therapy and sleep apnea.
ResMed, headquartered in Sydney, leads in CPAP devices and OSA solutions, capturing significant shares amid Philips' recalls, with expansions in ventilators. Masimo Corporation pioneers noninvasive pulse oximetry and capnography like Rad-97, aiding oxygenation monitoring across settings. Recent moves, such as SunMed's acquisitions from Vyaire and Avanos in 2023, bolster portfolios in breathing circuits and airway management, though SunMed ranks slightly lower. North America holds 26% revenue share, driven by COPD prevalence and reimbursements, while Asia-Pacific grows fastest. These firms prioritize infection control, portability, and digital integration amid aging populations and chronic disease surges.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for anesthesia and respiratory device market by geography and historical trend. The scope of the report extends to sizing of the anesthesia and respiratory device market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Medtronic PLC, GE Healthcare, Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, and B. Braun Melsungen AG lead the anesthesia and respiratory device market, alongside Smiths Medical, Teleflex Incorporated, Fisher & Paykel Healthcare, ResMed, and Masimo Corporation, dominating through innovations in ventilators, monitoring systems, and airway management. These companies drive a market valued at USD 50.45 billion in 2025, projected to reach USD 90.18 billion by 2034 at a 6.64% CAGR, fueled by rising respiratory disorders like COPD and surgical volumes. Medtronic, headquartered in Ireland, excels in advanced ventilators and anesthesia delivery, integrating AI for patient outcomes across cardiovascular and respiratory care. GE Healthcare, based in Chicago, offers cutting-edge anesthesia workstations with real-time monitoring and digital connectivity for global hospitals. Philips, from Amsterdam, provides modular monitoring and noninvasive ventilation, emphasizing AI analytics and interoperability.
Drägerwerk AG & Co. KGaA, in Lübeck, Germany, specializes in anesthesia machines, ventilators, and patient monitoring, supporting critical care worldwide since 1889. B. Braun Melsungen AG delivers infusion pumps, regional anesthesia systems, and safety needles, enhancing perioperative workflows. Smiths Medical (ICU Medical) focuses on airway devices like endotracheal tubes and infusion therapy for vital care. Teleflex Incorporated advances critical care with laryngeal masks and intubation tools, improving surgical efficiency. Fisher & Paykel Healthcare, from New Zealand, innovates in humidifiers and masks for acute respiratory therapy and sleep apnea.
ResMed, headquartered in Sydney, leads in CPAP devices and OSA solutions, capturing significant shares amid Philips' recalls, with expansions in ventilators. Masimo Corporation pioneers noninvasive pulse oximetry and capnography like Rad-97, aiding oxygenation monitoring across settings. Recent moves, such as SunMed's acquisitions from Vyaire and Avanos in 2023, bolster portfolios in breathing circuits and airway management, though SunMed ranks slightly lower. North America holds 26% revenue share, driven by COPD prevalence and reimbursements, while Asia-Pacific grows fastest. These firms prioritize infection control, portability, and digital integration amid aging populations and chronic disease surges.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.